Mark Andrew White - Apr 8, 2024 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
General Manager, Commercial Affairs
Signature
/s/ Martin Wilson, as attorney-in-fact for Mark Andrew White
Stock symbol
RCKT
Transactions as of
Apr 8, 2024
Transactions value $
-$308,763
Form type
4
Date filed
4/10/2024, 08:39 PM
Previous filing
Feb 21, 2024
Next filing
Jul 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RCKT Common Stock Sale -$309K -12.5K -14.28% $24.64 75.2K Apr 8, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. RSUs vest one-third (1/3) upon the first anniversary of the grant date, with the remaining shares vesting in equal quarterly installments over the following two years.

Remarks:

General Manager, Commercial Affairs